by Jessica Casebolt | Jul 12, 2023 | M&A, Tea Leaves
Bright Health Group announced that it will sell its final insurance assets to Molina Healthcare for up to $600 million in cash. Bright Health needed to ink a proposed sale agreement for its Medicare Advantage business in California by Friday to avoid bankruptcy after...
by Jessica Casebolt | Jun 26, 2023 | M&A, Tea Leaves
Digital health company Babylon Health finalized plans to go private and will combine with digital therapeutics company MindMaze. The combination of Babylon Health and MindMaze will form a “powerful digital-first global AI-driven health care business that will...
by Jessica Casebolt | Jun 21, 2023 | M&A, Tea Leaves
Eli Lilly announced Tuesday that it has entered into a deal to acquire Dice Therapeutics for $2.4 billion, a move that will bulk up its treatment portfolio for immune-related diseases. Dice is a biopharmaceutical company that uses a proprietary technology platform to...
by Jessica Casebolt | Jun 12, 2023 | M&A, Tea Leaves
Walgreens Boots Alliance sold its remaining stake in post-acute care and infusion services company Option Care Health for $330 million. The drugstore chain announced Thursday it sold 10.8 million shares of Option Care Health and plans to use the proceeds primarily for...
by Jessica Casebolt | Jun 5, 2023 | M&A, Tea Leaves
BJC HealthCare of St. Louis and Saint Luke’s Health System of Kansas City said that they are exploring a merger that could create a 28-hospital academic health system valued at around $10 billion. The combined company wouldn’t have geographic overlap,...
by Jessica Casebolt | May 16, 2023 | M&A, Tea Leaves
The U.S. Federal Trade Commission is expected to file a lawsuit as early as Tuesday to block Amgen Inc’s $27.8 billion deal to buy Horizon Therapeutics PLC. Amgen struck a deal last year to buy Horizon to strengthen its rare diseases drugs portfolio. The company...
Recent Comments